• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性大麻素系统与体力活动——代谢紊乱新型治疗方法中的强大组合。

The Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders.

机构信息

Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.

Department of Ophthalmology, Antoni Jurasz University Hospital No. 1, 85-094 Bydgoszcz, Poland.

出版信息

Int J Mol Sci. 2022 Mar 12;23(6):3083. doi: 10.3390/ijms23063083.

DOI:10.3390/ijms23063083
PMID:35328503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948925/
Abstract

Rapidly increasing worldwide prevalence of obesity and related pathologies encompassing coronary heart disease, hypertension, metabolic syndrome, or type 2 diabetes constitute serious threats to global health and are associated with a significantly elevated risk of premature death. Considering the enormous burden of these pathologies, novel therapeutic and preventive patterns are indispensable. Dysregulation of one of the most complex biological systems in the human body namely, the endocannabinoid system (ECS) may result in metabolic imbalance and development of insulin resistance, type 2 diabetes, or non-alcoholic fatty liver disease. Furthermore, many studies showed that physical exercises, depending on their type, intensity, and frequency, exert various alterations within the ECS. Emerging evidence suggests that targeting the ECS via physical activity may produce robust beneficial effects on the course of metabolic pathologies. However, the data showing a direct correlation between the ECS and physical activity in the aspect of metabolic health are very scarce. Therefore, the aim of this review was to provide the most up-to-date state of knowledge about the interplay between the ECS activity and physical exercises in the novel therapeutic and preventive approach toward metabolic pathologies. We believe that this paper, at least in part, will fulfill the existing gap in knowledge and encourage researchers to further explore this very complex yet interesting link between the ECS, its action in physical activity, and subsequent positive outcomes for metabolic health.

摘要

肥胖及其相关疾病(包括冠心病、高血压、代谢综合征或 2 型糖尿病)在全球范围内的患病率迅速上升,对全球健康构成严重威胁,并与过早死亡的风险显著增加相关。考虑到这些疾病的巨大负担,新型治疗和预防模式是必不可少的。人体中最复杂的生物系统之一——内源性大麻素系统(ECS)的失调可能导致代谢失衡和胰岛素抵抗、2 型糖尿病或非酒精性脂肪性肝病的发展。此外,许多研究表明,运动的类型、强度和频率会对内源性大麻素系统产生各种影响。新出现的证据表明,通过体育活动靶向内源性大麻素系统可能对代谢疾病的进程产生强大的有益影响。然而,在代谢健康方面,内源性大麻素系统与体育活动之间存在直接相关性的数据非常有限。因此,本综述的目的是提供关于 ECS 活性与体育锻炼在代谢疾病的新型治疗和预防方法中的相互作用的最新知识状况。我们相信,本文至少在一定程度上填补了现有知识空白,并鼓励研究人员进一步探索 ECS 及其在体育活动中的作用,以及对代谢健康产生的后续积极影响之间非常复杂但有趣的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/8948925/ba3d8e38e47b/ijms-23-03083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/8948925/775833d400a5/ijms-23-03083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/8948925/ba3d8e38e47b/ijms-23-03083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/8948925/775833d400a5/ijms-23-03083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/8948925/ba3d8e38e47b/ijms-23-03083-g002.jpg

相似文献

1
The Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders.内源性大麻素系统与体力活动——代谢紊乱新型治疗方法中的强大组合。
Int J Mol Sci. 2022 Mar 12;23(6):3083. doi: 10.3390/ijms23063083.
2
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.第二代 CB1 受体阻滞剂和其他外周型内源性大麻素活性过度抑制剂及其在代谢紊乱治疗中的作用机制。
Expert Opin Investig Drugs. 2012 Sep;21(9):1309-22. doi: 10.1517/13543784.2012.704019. Epub 2012 Jul 11.
3
Endocannabinoids and Metabolic Disorders.内源性大麻素与代谢紊乱
Handb Exp Pharmacol. 2015;231:367-91. doi: 10.1007/978-3-319-20825-1_13.
4
Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.内源性大麻素信号系统的药物治疗靶点:用于治疗肥胖症和代谢综合征的药物
Physiol Behav. 2008 Mar 18;93(4-5):671-86. doi: 10.1016/j.physbeh.2007.11.012. Epub 2007 Nov 21.
5
Peripheral modulation of the endocannabinoid system in metabolic disease.代谢性疾病中环核苷酸系统的外周调节。
Drug Discov Today. 2018 Mar;23(3):592-604. doi: 10.1016/j.drudis.2018.01.029. Epub 2018 Jan 10.
6
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease.内源性大麻素系统:肥胖症和代谢性疾病的关键协调器。
Trends Endocrinol Metab. 2015 Oct;26(10):524-537. doi: 10.1016/j.tem.2015.07.007.
7
Diet, endocannabinoids, and health.饮食、内源性大麻素与健康。
Nutr Res. 2019 Oct;70:32-39. doi: 10.1016/j.nutres.2019.06.003. Epub 2019 Jun 15.
8
Overactivation of the endocannabinoid system alters the antilipolytic action of insulin in mouse adipose tissue.内源性大麻素系统的过度激活会改变胰岛素在小鼠脂肪组织中的抗脂解作用。
Am J Physiol Endocrinol Metab. 2017 Jul 1;313(1):E26-E36. doi: 10.1152/ajpendo.00374.2016. Epub 2017 Mar 21.
9
Endocannabinoids, FOXO and the metabolic syndrome: redox, function and tipping point--the view from two systems.内源性大麻素、FOXO 和代谢综合征:氧化还原、功能和临界点——从两个系统看。
Immunobiology. 2010 Aug;215(8):617-28. doi: 10.1016/j.imbio.2009.03.005. Epub 2009 May 19.
10
Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise.内源性大麻素系统在调节骨骼肌对运动的反应中的作用。
Curr Opin Pharmacol. 2020 Jun;52:52-60. doi: 10.1016/j.coph.2020.05.003. Epub 2020 Jun 30.

引用本文的文献

1
Effects of five cannabis oils with different CBD: THC ratios and terpenes on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor in an experimental model.五种具有不同CBD:THC比例和萜烯成分的大麻油对实验模型中高血压、血脂异常、肝脂肪变性、氧化应激和CB1受体的影响。
J Cannabis Res. 2025 Jul 14;7(1):46. doi: 10.1186/s42238-025-00286-8.
2
The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management.四氢大麻酚酸(THCV)在代谢紊乱中的作用:一种治疗糖尿病和体重管理的有前景的大麻素。
AIMS Neurosci. 2025 Mar 12;12(1):32-43. doi: 10.3934/Neuroscience.2025003. eCollection 2025.
3

本文引用的文献

1
The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes.香豆雌酚对原代大鼠肝细胞中神经酰胺信号通路和胰岛素抵抗发展的影响。
Biomolecules. 2021 Feb 12;11(2):268. doi: 10.3390/biom11020268.
2
Phytocannabinoids-A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment.植物大麻素——一种治疗非酒精性脂肪性肝病的绿色方法。
J Clin Med. 2021 Jan 20;10(3):393. doi: 10.3390/jcm10030393.
3
The gut microbiome, endocannabinoids and metabolic disorders.肠道微生物组、内源性大麻素和代谢紊乱。
The Use of Cannabidiol in Metabolic Syndrome-An Opportunity to Improve the Patient's Health or Much Ado about Nothing?
大麻二酚在代谢综合征中的应用——是改善患者健康的契机还是小题大做?
J Clin Med. 2023 Jul 11;12(14):4620. doi: 10.3390/jcm12144620.
4
Beta-Caryophyllene Modifies Intracellular Lipid Composition in a Cell Model of Hepatic Steatosis by Acting through CB2 and PPAR Receptors.β-石竹烯通过作用于 CB2 和 PPAR 受体改变肝脂肪变性细胞模型中的细胞内脂质组成。
Int J Mol Sci. 2023 Mar 23;24(7):6060. doi: 10.3390/ijms24076060.
5
The Endocannabinoid System and Physical Exercise.内源性大麻素系统与体育锻炼。
Int J Mol Sci. 2023 Jan 19;24(3):1989. doi: 10.3390/ijms24031989.
6
Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome.地中海饮食干预3年期间内源性大麻素的性别差异:与代谢综合征人群胰岛素抵抗和体重减轻的关联
Front Nutr. 2022 Dec 1;9:1076677. doi: 10.3389/fnut.2022.1076677. eCollection 2022.
J Endocrinol. 2021 Feb;248(2):R83-R97. doi: 10.1530/JOE-20-0444.
4
A Closer Look at Anandamide Interaction With TRPV1.深入探究花生四烯乙醇胺与瞬时受体电位香草酸亚型1的相互作用。
Front Mol Biosci. 2020 Jul 21;7:144. doi: 10.3389/fmolb.2020.00144. eCollection 2020.
5
Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise.内源性大麻素系统在调节骨骼肌对运动的反应中的作用。
Curr Opin Pharmacol. 2020 Jun;52:52-60. doi: 10.1016/j.coph.2020.05.003. Epub 2020 Jun 30.
6
Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?体育活动可否支持神经障碍的预防和治疗中内源性大麻素系统?
Int J Mol Sci. 2020 Jun 13;21(12):4221. doi: 10.3390/ijms21124221.
7
Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives.内源性大麻素系统在健康和疾病中的作用:现状与未来展望。
Int J Mol Sci. 2020 May 18;21(10):3549. doi: 10.3390/ijms21103549.
8
Obesity subtypes, related biomarkers & heterogeneity.肥胖亚型、相关生物标志物和异质性。
Indian J Med Res. 2020 Jan;151(1):11-21. doi: 10.4103/ijmr.IJMR_1768_17.
9
The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease.大麻素 1 型受体拮抗剂对非酒精性脂肪性肝病肝氧化/硝化应激和炎症的影响。
Curr Med Chem. 2021;28(1):169-180. doi: 10.2174/0929867327666200303122734.
10
Treadmill exercise improves LPS-induced memory impairments via endocannabinoid receptors and cyclooxygenase enzymes.跑步机运动通过内源性大麻素受体和环氧化酶改善 LPS 诱导的记忆障碍。
Behav Brain Res. 2020 Feb 17;380:112440. doi: 10.1016/j.bbr.2019.112440. Epub 2019 Dec 19.